Hung-Ming Lam
University of Washington
H-index: 25
North America-United States
Top articles of Hung-Ming Lam
MP65-02 AIM HIGH: EPIGENETIC MODULATION AND IMMUNE STIMULATION IN BLADDER CANCER
The Journal of Urology
2024/5
MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER
The Journal of Urology
2024/5
Elucidating tumor evolution and heterogeneity in metastatic bladder cancer from rapid autopsies
Cancer Research
2024/3/22
Michael Yang
H-Index: 0
Hung-Ming Lam
H-Index: 22
AIM HIGH: EPIGENETIC MODULATION AND IMMUNE STIMULATION IN BLADDER CANCER
Urologic Oncology: Seminars and Original Investigations
2024/3/1
Khursheed Ali
H-Index: 8
Hung-Ming Lam
H-Index: 22
A combinatorial genetic strategy for exploring complex genotype–phenotype associations in cancer
Nature Genetics
2024/2/29
Shan Li
H-Index: 15
Alicia Wong
H-Index: 9
Vipul Bhatia
H-Index: 5
Qian Wu
H-Index: 4
Hung-Ming Lam
H-Index: 22
Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associations
bioRxiv
2023/4/14
A phase 1/2 study of rapamycin and cisplatin/gemcitabine for treatment of patients with muscle-invasive bladder cancer
Clinical Genitourinary Cancer
2023/4/1
Pharmacological NF‐κB inhibition decreases cisplatin chemoresistance in muscle‐invasive bladder cancer and reduces cisplatin‐induced toxicities.
Molecular Oncology
2023/12
Metastatic bladder cancer expression and subcellular localization of Nectin-4 and Trop-2 in variant histology: A rapid autopsy study
Clinical genitourinary cancer
2023/12/1
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression
Cancer Cell
2023/5/8
The dynamic roles of the bladder tumour microenvironment
2022/9
Hung-Ming Lam
H-Index: 22
Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy
Urologic oncology
2022/7
James Douglas
H-Index: 12
Hung-Ming Lam
H-Index: 22
Bladder cancer patient-derived organoids and avatars for personalized cancer discovery
2022/5/1
Hung-Ming Lam
H-Index: 22
PD53-09 Antibody drug conjugates and variant histology muscle-invasive bladder cancer: are the targets present in primary and/or metastatic tumors?
The Journal of Urology
2022/5
MP06-05 UROTHELIAL CANCER RAPID AUTOPSY PROGRAM: BIOSPECIMENS AND PATIENT-DERIVED PRECLINICAL MODELS
The Journal of Urology
2022/5
PD10-06 A PHASE 1/2 STUDY OF RAPAMYCIN AND CISPLATIN/GEMCITABINE FOR TREATMENT OF PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (NCT01938573)
The Journal of Urology
2022/5
Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer
Molecular Therapy
2022/4/6
RNA splicing factors SRRM3 and SRRM4 distinguish molecular phenotypes of castration-resistant neuroendocrine prostate cancer
Cancer research
2021/9/15
Regulation of telomere homeostasis and genomic stability in cancer by N6-adenosine methylation (m6A)
Science Advances
2021/7/28
mRNA translation is a therapeutic vulnerability necessary for bladder epithelial transformation
JCI insight
2021/6/6
Yuzhen Liu
H-Index: 1
Hung-Ming Lam
H-Index: 22
